Remove publications issue
article thumbnail

Public Health Matters - Current Issues in Oncology Space

Pharmacy Times

Christina Madison, PharmD, FCCP, AAHIVP, speaks with Ryan Haumschild, PharmD, MS, MBA, to discuss current issues in oncology, including drug shortages and patient access.

73
article thumbnail

Opinion: Peter Hotez is not alone: Online harassment of doctors is a public health issue

STAT

Father’s Day weekend was anything but calm on Twitter, which erupted as vaccine expert Peter Hotez was challenged online to a debate by podcaster and former reality TV host Joe Rogan.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Expert Panel Urges Clinicians to Get Involved With Public Health Issues

Pharmacy Times

In addition to the ongoing COVID-19 pandemic, significant public health concerns include opioid overdoses, maternal mortality disparities, and climate change.

144
144
article thumbnail

COVID-19 Perceived as Less Serious Than Other Respiratory Illness Despite Global Spotlight

Drug Topics

Study findings that identified non-COVID respiratory illness as the most serious health issue among members of low- and middle-income countries provide policymakers with a valuable lens through which to understand and address public health concerns.

211
211
article thumbnail

Pharmacy Focus: Conversations On Reproductive Health - Episode 2

Pharmacy Times

In this episode, we spoke with Dr. Christina Madison, founder and CEO of The Public Health Pharmacist, about why abortion access and reproductive care are public health issues.

129
129
article thumbnail

Examples of Advocacy in the Community for Public Policy Issues

Pharmacy Times

You just need to tell your story and be genuine and be real, and it makes such a difference.

73
article thumbnail

FDA-USPTO collaboration initiatives should be evidence-based, prioritize innovation

PhRMA

Food and Drug Administration (FDA) are in the process of considering new collaboration initiatives aimed at biopharmaceutical patents.

FDA 207